About TransOral Robotic Surgery (TORS)
April 12, 2012
Patients who have a tumor at the back of the throat, the swallowing tube or the base of the tongue now have a robotic option in lieu of a 10-12-hour open surgery that involves an incision to the jaw. Mount Sinai is one of the few centers in the world using a robot approach to work through the mouth to remove the tumor. This technology has changed the lives of our patients.
Dr. Eric Genden on Prominent Head and Neck Cancers
February 21, 2013
Mount Sinai's Dr. Eric Genden discusses the most common head and neck cancers and the worldwide epidemic of thyroid cancer and HPV-associated throat cancer.
Dr. Satish Govindaraj Discusses Testing for Sinusitis
February 20, 2013
His current research is focused on the impact of mucosal immunity in chronic sinusitis and quality of life after endoscopic skull base procedures.
Clinical Trial for Tonsil and Tongue Base Cancer
July 9, 2014
Researchers at Mount Sinai are now conducting a therapeutic clinical trial testing a novel vaccine (ADXS11-001) for patients with HPV-related oropharyngeal (tonsil and tongue base) cancer who are eligible to undergo robot-assisted surgery. Learn more about the Tisch Cancer Institute